NEW ENTERPRISE ASSOCIATES 17, L.P. -- MBX BIOSCIENCES, INC. 13D

Company

MBX Biosciences, Inc.

Filed

September 23, 2024

Accession Number

0001072613-24-000721

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →